HK46196A - Treatment of leukocyte dysfunction with gm-csf - Google Patents

Treatment of leukocyte dysfunction with gm-csf

Info

Publication number
HK46196A
HK46196A HK46196A HK46196A HK46196A HK 46196 A HK46196 A HK 46196A HK 46196 A HK46196 A HK 46196A HK 46196 A HK46196 A HK 46196A HK 46196 A HK46196 A HK 46196A
Authority
HK
Hong Kong
Prior art keywords
csf
dysfunction
treating
treatment
leukocyte
Prior art date
Application number
HK46196A
Other languages
English (en)
Inventor
Eric M Bonnem
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK46196A publication Critical patent/HK46196A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
HK46196A 1989-01-30 1996-03-14 Treatment of leukocyte dysfunction with gm-csf HK46196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30439189A 1989-01-30 1989-01-30

Publications (1)

Publication Number Publication Date
HK46196A true HK46196A (en) 1996-03-22

Family

ID=23176323

Family Applications (1)

Application Number Title Priority Date Filing Date
HK46196A HK46196A (en) 1989-01-30 1996-03-14 Treatment of leukocyte dysfunction with gm-csf

Country Status (21)

Country Link
US (1) US5178855A (xx)
EP (2) EP0382381B1 (xx)
JP (1) JPH0651640B2 (xx)
KR (1) KR0137361B1 (xx)
AT (1) ATE89737T1 (xx)
AU (1) AU633054B2 (xx)
CA (1) CA2045605C (xx)
DE (1) DE69001686T2 (xx)
DK (1) DK0382381T3 (xx)
ES (1) ES2055314T3 (xx)
FI (1) FI913625A0 (xx)
HK (1) HK46196A (xx)
HU (1) HU207229B (xx)
IE (1) IE64234B1 (xx)
IL (1) IL93219A (xx)
MY (1) MY105798A (xx)
NZ (1) NZ243953A (xx)
OA (1) OA09509A (xx)
PT (1) PT92995B (xx)
WO (1) WO1990008554A1 (xx)
ZA (1) ZA90600B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05506673A (ja) * 1991-02-22 1993-09-30 アムジエン・インコーポレーテツド 迅速な創傷の治癒を促進するためのｇｍ―ｃｓｆ及びｇ―ｃｓｆの使用
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
EP0661057A4 (en) * 1993-06-08 1997-09-03 Ajinomoto Kk ACCELERATOR OF THE PROLIFERATION OF HEMATOPIETIC CELLS.
AU704486B2 (en) * 1994-03-04 1999-04-22 Ludwig Institute For Cancer Research Animals with targeted gene disruption
US5942253A (en) 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US7153943B2 (en) * 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US6753165B1 (en) * 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
CA2673049C (en) * 2006-12-22 2016-02-23 Novadel Pharma Inc. Stable anti-nausea oral spray formulations and methods
US7697268B2 (en) * 2007-08-09 2010-04-13 Haworth, Inc. Modular electrical distribution system for a building

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
EP0238655A4 (en) * 1985-10-03 1989-09-11 Biogen Nv POLYPEPTIDES LIKE THE GRANULOCYTE-MACROPHOUS COLONY STIMULATION FACTORS (GM-CSF) AND THEIR METHODS OF PRODUCING LARGE QUANTITIES IN MICROBIAL CELLS.
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
AU589731B2 (en) * 1985-11-27 1989-10-19 Genetics Institute, Llc Colony stimulating factor for the treatment of aids-type diseases
EP0307402B1 (en) * 1986-05-06 1993-08-11 Genetics Institute, Inc. Production of m-csf
US5162111A (en) * 1986-07-30 1992-11-10 Grabstein Kenneth H Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
EP0276846A3 (en) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Colony-stimulating factor derivatives
EP0386109A1 (en) * 1987-11-12 1990-09-12 Schering Corporation Acceleration of bone formation with gm-csf

Also Published As

Publication number Publication date
EP0382381A1 (en) 1990-08-16
PT92995A (pt) 1990-07-31
EP0455726A1 (en) 1991-11-13
DK0382381T3 (da) 1993-07-12
NZ243953A (en) 1997-06-24
ATE89737T1 (de) 1993-06-15
JPH0651640B2 (ja) 1994-07-06
DE69001686T2 (de) 1993-09-02
IE900318L (en) 1990-07-30
EP0382381B1 (en) 1993-05-26
JPH03504980A (ja) 1991-10-31
PT92995B (pt) 1995-12-29
IL93219A0 (en) 1990-11-05
MY105798A (en) 1995-01-30
FI913625A0 (fi) 1991-07-30
HU207229B (en) 1993-03-29
AU633054B2 (en) 1993-01-21
CA2045605C (en) 1997-02-11
ES2055314T3 (es) 1994-08-16
DE69001686D1 (de) 1993-07-01
ZA90600B (en) 1990-10-31
OA09509A (en) 1992-11-15
IL93219A (en) 1998-12-27
WO1990008554A1 (en) 1990-08-09
IE64234B1 (en) 1995-07-26
HUT57607A (en) 1991-12-30
AU5048890A (en) 1990-08-24
KR910700069A (ko) 1991-03-13
KR0137361B1 (ko) 1998-04-25
CA2045605A1 (en) 1990-07-31
US5178855A (en) 1993-01-12

Similar Documents

Publication Publication Date Title
TW265265B (xx)
HUT63564A (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
EP0317568A4 (en) Use of stimulation of granulocyte-macrophage colonies for obtaining a medicament for the treatment of bacterial diseases.
HK46196A (en) Treatment of leukocyte dysfunction with gm-csf
GR3032224T3 (en) Therapeutic agent for threatened abortion.
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
GR3000751T3 (en) Tpa-containing medical composition and use thereof
EP0397211A3 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
粟坪华 et al. Observation on 38 cases of drug-induced myospasm treated with massage over the acupoints
周荣兴 et al. THE EFFECT OF ACUPUNCTURE ON THE PHAGOCYTIC ACTIVITY OF HUMAN LEUKOCYTES
Bantz et al. Ciprofloxacin treatment of deep respiratory tract infections.
Lowe et al. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
EP0282844A3 (en) Use of dopamine-agonists in the preparation of a medicament for the treatment of bone injuries
IL125789A (en) USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES
HUT54302A (en) Process for producing medicaments comprising gamma-interferon, suitable for treating cancer of the ovary
RU96115809A (ru) Способ лечения сочетанной челюстно-мозговой травмы

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)